Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Maravai refinances credit agreement, extends term loan maturity to June 2032

Positive Impact 3 of 5 financing Written later

On June 2, 2026, Maravai entered a new credit agreement with a $150.0 million term loan and a $30.0 million revolving credit facility, both maturing June 2, 2032. Loan proceeds and about $98.5 million of cash on hand were used to repay in full the prior credit agreement, which was due October 2027. The company says this reduces its long-term debt principal from about $242.9 million to $150.0 million, though the new term loan carries a variable rate of SOFR plus 5.00%.

Key points

  • New $150.0 million term loan and $30.0 million revolving credit facility, both maturing June 2, 2032.
  • Prior credit agreement, due October 2027, was prepaid in full and terminated on June 2, 2026.
  • Company states long-term debt principal falls from about $242.9 million to $150.0 million.
  • Term loan bears interest at SOFR plus 5.00% per annum; revolver carries a 0.50% annual commitment fee on unused amounts.

The filing

CompanyMARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
Form8-K, current report
Filed with the SECJun 3, 2026, 8:31 AM ET
Accession number0001823239-26-000049

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.